Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W Lewis

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 31, 2017
Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource UtilizationMatthew G J Trese, Andrew W Lewis, Taylor S Blachley, et al.
Physiology & Behavior|August 24, 2010
The effectiveness of vasopressin as an ACTH secretagogue in cattle differs with temperamentKevin O Curley, Don A Neuendorff, Andrew W Lewis, et al.
Hormones and Behavior|October 6, 2007
Functional characteristics of the bovine hypothalamic-pituitary-adrenal axis vary with temperamentKevin O Curley, Don A Neuendorff, Andrew W Lewis, et al.
Theriogenology|September 16, 2014
Effects of intraluteal implants of prostaglandin E1 or E2 on angiogenic growth factors in luteal tissue of Angus and Brahman cowsYoshie S Weems, Yan Ma, Stephen P Ford, et al.
Prostaglandins & Other Lipid Mediators|May 24, 2011
In vivo intra-luteal implants of prostaglandin (PG) E(1) or E(2) (PGE(1), PGE(2)) prevent luteolysis in cows. I. Luteal weight, circulating progesterone, mRNA for luteal luteinizing hormone (LH) receptor, and occupied and unoccupied luteal receptors for LHYoshie S Weems, J Alejandro Arreguin-Arevalo, Torrance M Nett, et al.
Prostaglandins & Other Lipid Mediators|November 29, 2011
In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. II: mRNA for PGF2α, EP1, EP2, EP3 (A-D), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissueYoshie S Weems, Phillip J Bridges, Myoungkun Jeoung, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 31, 2017
Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource UtilizationMatthew G J Trese, Andrew W Lewis, Taylor S Blachley, et al.
Physiology & Behavior|August 24, 2010
The effectiveness of vasopressin as an ACTH secretagogue in cattle differs with temperamentKevin O Curley, Don A Neuendorff, Andrew W Lewis, et al.
Hormones and Behavior|October 6, 2007
Functional characteristics of the bovine hypothalamic-pituitary-adrenal axis vary with temperamentKevin O Curley, Don A Neuendorff, Andrew W Lewis, et al.
Theriogenology|September 16, 2014
Effects of intraluteal implants of prostaglandin E1 or E2 on angiogenic growth factors in luteal tissue of Angus and Brahman cowsYoshie S Weems, Yan Ma, Stephen P Ford, et al.
Prostaglandins & Other Lipid Mediators|May 24, 2011
In vivo intra-luteal implants of prostaglandin (PG) E(1) or E(2) (PGE(1), PGE(2)) prevent luteolysis in cows. I. Luteal weight, circulating progesterone, mRNA for luteal luteinizing hormone (LH) receptor, and occupied and unoccupied luteal receptors for LHYoshie S Weems, J Alejandro Arreguin-Arevalo, Torrance M Nett, et al.
Prostaglandins & Other Lipid Mediators|November 29, 2011
In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. II: mRNA for PGF2α, EP1, EP2, EP3 (A-D), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissueYoshie S Weems, Phillip J Bridges, Myoungkun Jeoung, et al.
Pageof 1